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Abstract
Cystic fibrosis (CF) patients are hypersusceptible to chronic Pseudomonas aeruginosa lung
infections. Cultured human airway epithelial cells expressing the ΔF508 allele of the cystic
fibrosis transmembrane conductance regulator (CFTR) were defective in uptake of P. aeruginosa
compared with cells expressing the wild-type allele. Pseudomonas aeruginosa lipopolysaccharide
(LPS)–core oligosaccharide was identified as the bacterial ligand for epithelial cell ingestion;
exogenous oligosaccharide inhibited bacterial ingestion in a neonatal mouse model, resulting in
increased amounts of bacteria in the lungs. CFTR may contribute to a host-defense mechanism
that is important for clearance of P. aeruginosa from the respiratory tract.
Among the most serious manifestations of CF are chronic pulmonary infections with the
bacterium P. aeruginosa. The basis for hypersusceptibility of CF patients to this bacterium is
not well understood, and the role of mutant CFTR, if any, is not clear. Binding and
internalization of respiratory pathogens by epithelial cells followed by desquamation could
be an important mechanism for clearing bacteria from the lung. This mechanism has been
shown to be important in protecting against bladder infections (1).
To investigate whether the most common and severe CFTR mutation (ΔF508) affected
uptake of P. aeruginosa, we performed bacterial invasion assays (2) with four cell lines:
CFT1, an airway epithelial cell line derived from a CF patient homozygous for ΔF508
CFTR and that is transformed with human papilloma virus 18 E6/E7; CFT1-ΔF508, which
expresses a third copy of ΔF508 CFTR introduced by a retrovirus; CFT1-LC3, which
expresses a control gene (β-galactosidase) introduced by the same retrovirus; and CFT1-
LCFSN, which expresses a functional wild-type human CFTR gene (3). We tested a
standard laboratory strain of P. aeruginosa, designated PAOI, and two nonmucoid, LPS-
smooth clinical isolates from CF patients (4). Compared with CFT1-LCFSN cells, the three
lines expressing ΔF508 CFTR internalized significantly fewer bacterial cells (Fig. 1A). The
ΔF508 mutation causes inefficient processing of CFTR, a defect that is partially corrected if
the cells are grown at 26°C (5). When epithelial cells were cultured for 72 hours at 26°C
there were no longer significant differences in uptake of the P. aeruginosa strains by the
cells expressing wild-type or mutant CFTR (Fig. 1B). Because the overall uptake of bacteria
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at 26°C was low, we performed additional experiments with cells grown for 72 hours at
26°C in which the invasion assay was performed at 37°C for 3 hours, conditions under
which surface expression of mutant ΔF508 CFTR is maintained (5). No significant
difference in bacterial cell uptake was measured (Fig. 1C), and overall amounts of
internalization approached those of the CFT1-LCFSN cells at 37°C. Returning cells
expressing ΔF508 CFTR to 37°C for 24 hours after growth for 72 hours at 26°C removes
CFTR from the cell surface (5); under these conditions internalization of the bacterial strains
was essentially identical to that shown in Fig. 1A (6). These data indicate that internalization
of P. aeruginosa by airway epithelial cells correlated with membrane expression of CFTR.
The effect of ΔF508 CFTR on ingestion appeared to be specific for P. aeruginosa; other
bacterial pathogens tested (7) were internalized equally well by cells expressing mutant
ΔF508 or wild-type CFTR. Quantitative bacterial binding assays revealed that differences in
internalization by the epithelial cells were not simiply due to differences in the adherence of
P. aeruginosa.
Over the course of chronic lung infection in CF patients, variants of P. aeruginosa emerge
that no longer express complete LPS structures (8). To investigate the effect of LPS
structure on epithelial cell internalization, we tested eight P. aeruginosa strains that differ in
LPS structure (9) (Fig. 2, A and B). Maximal invasion occurred into the CFT1-LCFSN cells
by bacterial strains expressing an intact LPS outer core; in addition, cells expressing wild-
type CFTR ingested significantly more P. aeruginosa, regardless of LPS phenotype, than did
those expressing ΔF508 CFTR. No effect on bacterial ingestion was seen when isogenic P.
aeruginosa strains differing in production of pili, flagella, or mucoid exopolysaccharide were
tested (6).
We also compared the internalization of three clinical isolates of P. aeruginosa with
incomplete LPS structures with that of recombinant strains converted back to expression of
complete LPS structures by introduction of portions of the rfb locus of P. aeruginosa strain
PA103 (10). All three recombinant LPS-smnooth bacterial strains showed the same pattern
of ingestion by the cell lines (Fig. 2, C to E) as was depicted in Figs. 1 and 2, A and B, for
naturally occurring LPS-smooth strains. Uptake of the recomnbinant LPS-smooth strains by
all of the cell lines was significantly increased compared with the LPS-incomplete clinical
isolates carrying only the vector for DNA cloning. These results suggest that the emergence
of strains expressing an incomplete LPS structure during chronic infection of CF patients
may further reduce epithelial cell uptake and thus contribute to bacterial survival in the
airways.
To determine if LPS could inhibit the internalization of P. aeruginosa, we isolalted LPS and
the oligosaccharide fraggment lacking lipid A from strains PAC557 and PACIR algC∷tet
and tested their inhibitory activity in the invasion assay. Strain PAC557 produces an LPS
with a comnplete core but no O side chains, and the isogenic strain PACIR algC∷tet
expresses an incomplete LPS core (11). LPS from the former, but not the latter, strain
inhibited ingestion by the CFT1-LCFSN cells (Fig. 3). LPS with a complete core also
inhibited bacterial adherence to the CFT1-LCFSN cell line (12). These results suggest that
the complete LPS outer core is an important bacterial ligand involved in the ingestion by
airway epithelial cells expressing wild-type CFTR. LPS has a similar role in the invasion of
epithelial cells by Neisseria gonorrhocae (13).
To assess the physiological significance of these observations, we used a neonatal mouse
model for infection by P. aeruginosa wherein epithelial cell internalization of bacteria has
been observed (14). Inocula containing P. aeruginosa PAO1 plus complete-core
oligosaccharide produced fewer intracellular P. aeruginosa 1 and 24 hours after infection
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compared with controls inoculated with PAOI alone or PAOI plus incomiplete-core
oligosaccharide (Fig. 4). The total number of bacteria in the lung at 1 hour was the same for
all groups, but at 24 hours there were ≥28 million more P. aeruginosa per gram of lung
tissue when the complete-core oligosaccharide was added to the inoculum. Forty-eight hours
after infection, the mice given the complete-core inhibitor still had substantially more
bacteria in the lungs compared with controls. Mice given the complete-core inhibitor had
more internalized bacteria at 48 hours, although this was not significantly different (P >
0.05) from mice given incomplete-core inhibitor; presumably this higher level of
internalized bacteria reflected the fact that there were more total bacteria in these mouse
lungs and there would be no effect from the inhibitor at this time point. In a separate
experiment, addition of intact LPS to the bacterial inoculum produced similar results (6).
Thus, additioin of an exogenous ligand to block bacterial ingestion by epithelial cells
resulted in less bacterial clearance from the lungs of neonatal mice.
Histological analyses of affected lung tissue removed from CF patients at autopsy or for
transplantation routinely show that P. aeruginosa cannot be seen internalized with-in airway
cells and are rarely attached to epithelial cells. Instead, bacteria are observed as
microcolonies encased in the extracellular mucus layer lying in the airway lumen (15). Thus,
our findings are consistent with the observed histopathology. Some studies have implicated
increased receptors for P. aeruginosa on epithelial cells from CF patients as the basis for the
hypersusceptibility of CF patients to chronic infection (16), whereas others have reported no
differences in P. aeruginosa adherence to nasal polyp epithelial cells cultured from
individuals with and without CF (17). Further studies are needed to determine the relation
between binding of P. aeruginosa and internalization by epithelial cells and the pathogenesis
of chronic lung infection in CF patients.
Our results suggest that P. aeruginosa can initiate infection in CF patients because airway
epithelial cells expressing a mutant CFTR are defective in internalization of the bacterium, a
process that may be an important host defense. The emergence during chronic infection of P.
aeruginosa variants with an incomplete LPS structure, which would further impair their
internalization, may contribute to the maintenance of the infectious state. Conceivably,
genetic or other therapies that promote expression of CFTR on epithelial cell surfaces could
enhance elimination of P. aeruginosa by cellular uptake and alter the otherwise relentless
clinical course of CF.
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Internalization of P. aeruginosa by 105 transformed airway epithelial cells (2). Cells were
grown for 72 hours and bacteria were then allowed to invade the cells for 3 or 4 hours. Bars
indicate the mean of the determinations and error bars the SD. Cell lines are as follows: 1,
CFT1-LCFSN; 2, CFT1; 3, CFT1-LC3; and 4, CFT1-ΔF508. (A) Cells were grown at 37°C,
a temperature that inhibits membrane expression of ΔF508 CFTR (5) and the assay was
carried out at 37°C. Multiple comparisons for all three bacterial strains were significant (P <
0.001, ANOVA); the CFT1-LCFSN line was significantly different from any other cell line
(P < 0.01, Fisher's PLSD statistic) for all three bacterial strains. (B) Cells were grown at
26°C and internalization was assessed at 26°C. (C) Cells were grown at 26°C and
internalization was assessed at 37°C. When cells were grown at 26°C to promote surface
expression of ΔF508 CFTR (5), there were no significant (P > 0.2, ANOVA) differences in
bacterial uptake among the cell lines for any P. aeruginosa strain tested.
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Role of the complete outer-core region of P. aeruginosa LPS in internalization by airway
epithelial cells (2). Bars indicate the mean of the determinations and error bars the SD. (A
and B) Assays with bacterial strains of defined LPS phenotype (9); 1, PAC1 R, wild-type,
smooth; 2, PAC557, complete core; 3, PAC1R algC::tet, incomplete core; 4, PAC605,
incomplete core; 5, PAO1, wild-type, smooth; 6, AK44, complete core; 7, PAO1 algC::tet,
incomplete core; and 8, AK1012, incomplete core. All eight strains were internalized by the
CFT1-LCFSN cell line significantly better than by the three cell lines expressing mutant
ΔF508 CFTR (P < 0.001, ANOVA; P < 0.05 for all pair-wise comparisons, Fisher PLSD).
Bacterial strains with a smooth or complete-core LPS were internalized by all of the cell
lines significantly better than strains expressing an incomplete core (P < 0.01, ANOVA; P <
0.05 for all pair-wise comparisons, Fisher PLSD). (C to E) Increased internalization by
airway epithelial cells of recombinant LPS-smooth P. aeruginosa strains carrying cloned rfb
genes (solid bars) compared with parental clinical isolates expressing an incomplete LPS
structure and carrying only the DNA cloning vector (open bars) (10). (C) Strain 2192; (D)
strain 332; (E) strain 9125. Ingestion of all of the LPS-smooth strains by all of the cell lines
was significantly better than ingestion of the corresponding LPS-incomplete isolate (P ≤
0.002, unpaired t test), except for strain 9125 by the CFT1 cells. There was also significantly
greater (P < 0.001, ANOVA) uptake of all of the LPS-smooth bacteria by the CFT1-LCFSN
cells compared with the other three cell lines expressing ΔF508 CFTR.
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Effect of intact LPS (A) and an oligosaccharide with a lipid A–free core (B) on
internalization of P. aeruginosa into CFT1-LCFSN cells. Each point is the mean of three to
seven replicates; error bars are SD. Pseudomonas aeruginosa strains: (□), PAO1; (Δ), 149;
and (Ο), 324. Solid symbols in (B) represent the mean CFU of bacteria internalized in the
presence of intact LPS (100 μg/ml) from strain PAC1R algC::tet, which has an incomplete-
core oligosaccharide. Amounts of internalization < 104 CFU differed significantly (P < 0.01,
ANOVA and Fisher PLSD for pair-wise comparisons) from amounts of internalization in
the presence of incomplete-core LPS (100 μg/ml).
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Effect of complete-core oligosaccharide on P. aeruginosa infection in neonatal mouse lungs.
Each point indicates the median bacterial CFU for 8 to 10 lungs obtained from each group of
mice and the bars indicate the upper and lower quartiles. Inhibitor delivered with inoculum:
(●), none; (□), complete-core oligosaccharide; and (■), incomplete-core oligosaccharide.
Groups of 7-day-old neonatal BALB/c mice were infected intranasally with ~ 108 CFU of
strain PAO1 (14) alone or mixed with either complete-core oligosaccharide (50 μg) or
incomplete-core oligosaccharide (50 μg) (11). After 1, 24, or 48 hours, four to five mice
were killed and their lungs were removed, weighed, and dispersed into single-cell
suspensions. The total CFU of bacteria present in each lung was determined from a sample
treated with Triton X-100 (0.5%) to release intracellular bacteria. The remaining cells were
treated with gentamicin (300 μg/ml) for 60 min to kill extracellular P. aeruginosa, then the
cells were centrifuged, washed twice in tissue-culture medium, and resuspended in 200 μl of
0.5% Triton X-100 to release intracellular bacteria. These suspensions were diluted and
plated. Differences among groups were analyzed by nonparametric statistics: P < 0.0001,
Kruskall-Wallis nonparametric ANOVA; P < 0.001, Dunn procedure for individual pair-
wise differences between the groups at 1 and 24 hours. Also, at 1 hour the group receiving
the incomplete-core oligosaccharide had a reduced amount (P = 0.05, Dunn procedure) of
intracellular bacteria compared with the group receiving nothing with the inoculum. At 48
hours, the group treated initially with complete-core inhibitor had significantly more
bacteria in their lungs (P = 0.003, Kruskall-Wallis; P < 0.05, Dunn procedure for all pair-
wise comparisons) than did the other groups.
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